(Q35139846)

6 August 2017

1 reference

title

Impact of obesity in the setting of high-dose chemotherapy (English)

1 reference

6 August 2017

0 references

1 reference

Navarro WH

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Bone Marrow Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

31

1 reference

6 August 2017

issue

11

1 reference

6 August 2017

page(s)

961-966

1 reference

Divergent trends in obesity and fat intake patterns: the American paradox.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Doxorubicin clearance in the obese

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Obesity and autologous stem cell transplantation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704052

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704052

1 reference

Dimensions Publication ID

6 August 2017

1040729559

0 references

1 reference